Diagnostic Tests/Kits Products & Reviews

For the specific detection of the coronavirus causing COVID-19

Characterize MSI Status of Your Research Samples

The Maxpar Direct Immune Profiling Assay™ sets a new standard for comprehensive immunophenotyping of human PBMC and whole blood by enabling simultaneous identification and enumeration of 37 immune cell subsets.  30 markers. 1 tube. 5-minute data analysis.

Anti-Mullerian Hormone (AMH) immunoassay is a useful research tool in reproductive endocrinology studies related to primary ovarian insufficiency, oncofertility, gonadotoxicity, menopause, premature ovarian aging, PCOS, neonatal gender determination, Cryptorchidism, Testicular (Leydig/Sertoli cell) function.

The Inhibin A enzyme linked immunosorbent assay (ELISA) kit provides materials for the quantitative measurement of dimeric inhibin A in human serum and plasma. It is intended for in vitro diagnostic use as an aid in the diagnosis and monitoring of various hormonal reproductive disorders.

Elevated levels of activin A have been implicated in colorectal and breast cancers in post-menopausal women. FST and FSTL3 are natural binding proteins of activin A. Exogenous FST/FSTL3 do not interfere with activin A determinations. Activin signaling also has been studied as an emerging target for therapeutics.

Inhibin B is a useful research tool in Reproductive Endocrinology studies related to ovarian function assessment, spermatogenesis and testicular function, and oocyte quality.

The Ansh Labs' Bovine Anti-Müllerian hormone (AMH) enzyme-linked immunosorbent assay (ELISA) kit is the only AMH assay designed specifically for use in cattle.  Numerous publications, collaborations, dissertations, and similar studies have used the Ansh Labs' Bovine AMH ELISA asasy in countless breeds to include Jersey, Hereford, Holstein, Angus, Red Angus, Black Angus, Brahman, Gyr, Nelore, Murrah, Beefmaster, Brangus, Holste…

The MenoCheck® picoAMH ELISA is FDA cleared for in vitro diagnostic use as an aid in the determination of menopausal status in women between 42 and 62 years of age. This is the only AMH test with the sensitivity to quantify declining AMH concentrations in women who are entering their menopausal transition.

The Anti-SARS-CoV-2 QuantiVac ELISA (IgG) provides quantitative measurement of IgG antibodies against the S1 antigen (including RBD) of SARS-CoV-2. The antibody concentration is determined in standardised binding antibody units (BAU/ml) according to international reference material. The test supports assessment of the level of immune reaction following SARS-CoV-2 infection or vaccination with spike protein-based vaccines.